Fundz

Aliada Therapeutics reported raising $32 Million in an initial SEC Form D filing, from an offering of $32 Million

RECENTLY ACQUIREDDec 30, 2022

Amount Raised

$32 Million

$32 Million sold, per SEC Form D (first sale Dec 23, 2022)

Round Type

Venture

BostonBiotechnology

Quick answer

Aliada Therapeutics raised $32 Million in a funding round, dated December 23, 2022. Aliada Therapeutics is based in Boston, Massachusetts, United States.

How much did Aliada Therapeutics raise?
Aliada Therapeutics raised $32 Million in a funding round on December 23, 2022.
What does Aliada Therapeutics do?
Biologics are transforming the treatment of numerous diseases, but many CNS diseases remain largely out of reach due to the challenge of crossing the blood-brain barrier and navigating the brain’s unique immune..
Where is Aliada Therapeutics based and how big is it?
Aliada Therapeutics is based in Boston, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Aliada Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Sensible Biotechnologies raised $1.8M (Pre-Seed) on February 6, 2023.
  • Deka Biosciences, Inc. raised $30M on February 6, 2023.
  • Sabai Global raised an undisclosed amount on February 6, 2023.
  • 76Bio, Inc. raised $12M on February 6, 2023.
  • PaxMedica raised $3.2M (Seed) on February 3, 2023.
  • Incepto raised $3M (Seed) on February 3, 2023.

Who to call at Aliada Therapeutics, and when

A new round usually means Aliada Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aliada Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aliada Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aliada Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aliada Therapeutics

Location

200 BERKELEY STREET, 23rd FLOOR

Boston, Massachusetts, United States

About

Biologics are transforming the treatment of numerous diseases, but many CNS diseases remain largely out of reach due to the challenge of crossing the blood-brain barrier and navigating the brain’s unique immune environment. Aliada is redefining what is possible in CNS drug development by building on a highly versatile and differentiated platform, with demonstrated proof of concept in NHPs. We are expanding this platform across a wide range of modalities, including monoclonal antibodies, enzymes, oligonucleotides, peptides, and other proteins. The delivery technology is customizable to CNS tissue and target localization via novel approaches to binding two distinct transport targets on the blood-brain barrier. In addition to the platform, Aliada is applying its novel technology to specific CNS target antibody binders and progressing these programs through preclinical evaluation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aliada Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Aliada Therapeutics's next move

See what Strategic adds

Aliada Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.